IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,413,492 | +4.4% | 2,797,955 | -48.4% | 4.15% | -12.9% |
Q2 2023 | $102,842,630 | -10.8% | 5,421,330 | -27.1% | 4.76% | +0.5% |
Q1 2023 | $115,281,441 | -33.1% | 7,432,717 | -23.5% | 4.74% | -34.6% |
Q4 2022 | $172,352,500 | +213.3% | 9,710,000 | -1.5% | 7.24% | +187.1% |
Q3 2022 | $55,020,000 | +49.2% | 9,860,246 | +4.3% | 2.52% | +4.0% |
Q2 2022 | $36,875,000 | -7.4% | 9,455,000 | +30.9% | 2.42% | -5.1% |
Q1 2022 | $39,808,000 | -2.2% | 7,224,613 | +51.3% | 2.55% | -11.1% |
Q4 2021 | $40,683,000 | – | 4,775,000 | – | 2.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |